CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Pregnancy outcomes in Korean women with ankylosing spondylitis
Eun Hye Park, Jung Sun Lee, Ye-Jee Kim, Seung Mi Lee, Jong Kwan Jun, Eun Bong Lee, Yong-Gil Kim
    DOI: https://doi.org/10.3904/kjim.2019.144

Excel Download

Ankylosing spondylitis measures: The Ankylosing Spondylitis Quality of Life (ASQOL) Scale, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S), and Revised Leeds Disability Questionnaire (RLDQ)
Arthritis & Rheumatism. 2003;49(S5):S197-S209   Crossref logo
Link1 Link2

Ankylosing Spondylitis
Surgical Treatment of Ankylosing Spondylitis Deformity. 2019;3-13   Crossref logo
Link1

Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Sp
Arthritis Care & Research. 2011;63(S11):S47-S58   Crossref logo
Link1 Link2

Etanercept and infliximab costly for ankylosing spondylitis
PharmacoEconomics & Outcomes News. 2006;497(1):3-3   Crossref logo
Link1 Link2 Link3

Measures for assessing QOL in ankylosing spondylitis mainly valid
PharmacoEconomics & Outcomes News. 2004;451(1):10-10   Crossref logo
Link1 Link2 Link3

Infliximab cost effective for ankylosing spondylitis in the UK
PharmacoEconomics & Outcomes News. 2004;462(1):7-7   Crossref logo
Link1 Link2 Link3

Infliximab potentially cost saving in ankylosing spondylitis
PharmacoEconomics & Outcomes News. 2005;471(1):7-7   Crossref logo
Link1 Link2 Link3

Costs high for pain conditions vs ankylosing spondylitis
PharmacoEconomics & Outcomes News. 2005;473(1):6-6   Crossref logo
Link1 Link2 Link3

Infliximab worth it for ankylosing spondylitis in Canada . . .
PharmacoEconomics & Outcomes News. 2005;483(1):7-7   Crossref logo
Link1 Link2 Link3

EULAR presents new guidelines for arthritis, gout, ankylosing spondylitis
PharmacoEconomics & Outcomes News. 2005;480(1):2-2   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.